North America Drug Delivery Market - Forecasts from 2019 to 2024
The North America drug delivery market is projected to grow at a CAGR of 8.54% to reach US$505.060 billion by 2024, from US$308.903 billion in 2018. The drug delivery market in North America is poised to grow at a fast pace owing to the early adoption of technology, an aging population, and the prevalence of chronic diseases. Furthermore, high health expenditure is augmenting the market growth during the forecast period. However, stringent regulations for the approval of drugs and medical devices may impede the market growth during the forecast period.
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations being implemented by the relevant agencies. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the North America drug delivery value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the North America Drug Delivery market.
Major industry players profiled as part of the report are AstraZeneca group companies, West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Medtronic, and Boston Scientific Corporation among others.
Segmentation
The North America drug delivery market has been analyzed through following segments:
By Type
Inhalation Drug Delivery
Injectable Drug Delivery
Nasal Drug Delivery
Oral Drug Delivery
Transdermal Drug Delivery
By Application
Disease Treatment
Research/Academic purposes
By Country
USA
Canada
Mexico
Others
This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations being implemented by the relevant agencies. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.
Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the North America drug delivery value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.
Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the North America Drug Delivery market.
Major industry players profiled as part of the report are AstraZeneca group companies, West Pharmaceutical Services, Inc., Becton, Dickinson and Company, Medtronic, and Boston Scientific Corporation among others.
Segmentation
The North America drug delivery market has been analyzed through following segments:
By Type
Inhalation Drug Delivery
Injectable Drug Delivery
Nasal Drug Delivery
Oral Drug Delivery
Transdermal Drug Delivery
By Application
Disease Treatment
Research/Academic purposes
By Country
USA
Canada
Mexico
Others
1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NORTH AMERICA DRUG DELIVERY MARKET BY TYPE
5.1. Inhalation Drug Delivery
5.2. Injectable Drug Delivery
5.3. Nasal Drug Delivery
5.4. Oral Drug Delivery
5.5. Transdermal Drug Delivery
6. NORTH AMERICA DRUG DELIVERY MARKET BY APPLICATION
6.1. Disease Treatment
6.2. Research/Academic purposes
7. NORTH AMERICA DRUG DELIVERY MARKET BY COUNTRY
7.1. USA
7.2. Canada
7.3. Mexico
7.4. Others
8. COMPETITIVE INTELLIGENCE
8.1. Recent Deals and Investment
8.2. Competitive Benchmarking and Analysis
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. AstraZeneca group companies
9.2. West Pharmaceutical Services, Inc.
9.3. Becton, Dickinson and Company
9.4. Medtronic
9.5. Boston Scientific Corporation
9.6. Cipla Inc.
9.7. 3M
9.8. Ethypharm
9.9. Stevanato Group
9.10. Gerresheimer AG
LIST OF FIGURES
LIST OF TABLES
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Currency
1.5. Assumptions
1.6. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Secondary Sources
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter’s Five Force Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. NORTH AMERICA DRUG DELIVERY MARKET BY TYPE
5.1. Inhalation Drug Delivery
5.2. Injectable Drug Delivery
5.3. Nasal Drug Delivery
5.4. Oral Drug Delivery
5.5. Transdermal Drug Delivery
6. NORTH AMERICA DRUG DELIVERY MARKET BY APPLICATION
6.1. Disease Treatment
6.2. Research/Academic purposes
7. NORTH AMERICA DRUG DELIVERY MARKET BY COUNTRY
7.1. USA
7.2. Canada
7.3. Mexico
7.4. Others
8. COMPETITIVE INTELLIGENCE
8.1. Recent Deals and Investment
8.2. Competitive Benchmarking and Analysis
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. AstraZeneca group companies
9.2. West Pharmaceutical Services, Inc.
9.3. Becton, Dickinson and Company
9.4. Medtronic
9.5. Boston Scientific Corporation
9.6. Cipla Inc.
9.7. 3M
9.8. Ethypharm
9.9. Stevanato Group
9.10. Gerresheimer AG
LIST OF FIGURES
LIST OF TABLES
